BREAST Flashcards
The greatest benefit of radiation therapy in breast cancer
is seen in patients with
axillary node metastasis
large tumors
When offered post operatively, radiation can reduce the risk of local recurrence by 66%
Some studies have shown up to a 9% increase in survival when radiation was used with tamoxifen
Only 1-2% of patients develop a secondary malignancy attributable to the radiation treatment, usually after at least 10 years
Indications for xrt in breast cancer
ALWAYS lumpectomy
After mastectomy: Tumors >5cm (T3) Skin or chest wall involvement (T4) Tumor had + margins - really needs excision of margin? Inflammatory cancer
Nodes:
Extracapsular extension
Fixed axillary nodes (N2) > 4 positive axillary nodes
Indications for chemo in breast cancer
NEOadjuvant: T > 5cm Positive nodes Inflammatory breast cancer Triple negative breast cancer Trying to shrink tumor for lumpectomy Possible stratagy for pregnant waiting delivery
ADJUVANT
Tumor:
ANY tumor > 1cm! (CAREFUL don’t mix this up with xrt that is used for tumor greater than 5cm..)
Oncotype Dx especially for node -, ER + tumors
Recurrence
Nodes:
ANY positive nodes
Mets
Chemo agents
TAC Docetaxel (Taxotere) Doxorubicin (Adriamycin) cyclophosphamide AC ->T TC (heart problems) AC
papillomas
Solitary intraductal papillomas are true polyps of epithelium-lined breast ducts.
Solitary papillomas are most often located close to the areola but may be present in peripheral locations.
Most papillomas are less than 1 cm but can grow to as large as 4 or 5 cm.
Papillomas are NOT associated with an increased risk for breast cancer.
Papillomas are often accompanied by bloody nipple discharge. Less frequently, they are discovered as a palpable mass under the areola or as a density lesion on a mammogram.
Treatment is duct excision through a circumareolar incision.
Phyllodes tumors
are rare neoplasms defined by epithelial and stromal overgrowth.
Upwards of 50% have malignant potential based upon the cellular atypia, mitotic
activity, and stromal overgrowth! (CAREFUL this seems high)
Although the majority resemble fibroadenomas, the risk of malignancy warrants
surgical excision as the standard of care
Even though radiation therapy has proven to be beneficial in reducing local recurrence, there is no role for chemotherapy in the treatment of phyllodes tumors
Calcified rim lesion on mammography is consistent with
oil cyst (fat necrosis of breast tissue)
radiologic diagnosis can be made.
no bx need even if palp
histology consistent with oil syst
fat necrosis reveal lymphocytes, histiocytes, fat necrosis, and saponification.
Occult breast cancer presents with axillary adenopathy and NO evidence of the primary breast lesion work up
First, biopsy of the axillary adenopathy
If adenocarcinoma is detected the most likely source is the ipsilateral breast.
Next, imaging studies including mammogram AND MRI! to search for the primary lesion.
If negative, do NOT do whole body imaging as the next step as the likelihood of a primary breast lesion is nearly 100%.
Occult breast cancer presents with axillary adenopathy and NO evidence of the primary breast lesion tx
In the setting of negative mammogram and MRI with axillary node adenocarcinoma, treatment should consist of
axillary lymph node dissection,
chemo
AND endocrine therapy (even though you do not know hormone status)!!!
then whole breast RADIATION to the breast.
Historically, mastectomy was the treatment for these patients but has proven to be unnecessary.
Injections of radioactively labeled colloid have demonstrated that about what percent drains into the axilla versus the internal mammary nodes
97% of the lymphatic flow from the breast drains directly into the axillary lymph nodes, with the remaining 3% draining into the internal mammary nodes.
The axillary space is bordered by
the axillary vein superiorly,
the latissimus dorsi laterally,
the serratus anterior medially.
pectoralis major lies anterior to the axillary space,
subscapularis comprises its posterior wall.
histologic findings that require an excisional biopsy include
Atypical ductal hyperplasia!
lobular carcinoma in situ,
radial scar,
papillary lesion.
Sentinel lymph node biopsy (SLNB) is indicated for
almost all INVASIVE breast cancer with a negative axillary nodal exam
A positive nodal exam warrants an axillary dissection.
Sentinel lymph node biopsy (SLNB) is contraindicated for
contraindicated in inflammatory breast cancer because the results are inaccurate.
Relative contraindications include: increased size of tumor, multi- centricity, or previous surgery that may have disrupted the lymphatic drainage, such as breast augmentation - THIS IS RELATIVE
Previous excisional biopsy is not a contraindication to SLNB
SLNB is not usually performed for in situ disease because the tumor cells have not
breached the basement membrane
Extremity Soft tissue mass work up
MRI
Tissue via :
CNB for
hard, fixed to underlying structures, immobile,
more than 5 cm in size,
or
deep in location (subfascial or intramuscular)
It usually
provides adequate tissue to make the diagnosis and it is less invasive than open biopsy.
Excisional biopsy ONLY if CORE NEEDLE BX FAILED and is LESS THAN 3 cm
Incisional biopsy ONLY if CORE NEEDLE BX FAILED and is 3 cm of LARGER
Atypical ductal hyperplasia is a proliferative lesion with atypia and is associated with a relative risk of
4-5 of being diagnosed with breast in 10-20 years.
Benign histologies associated with no relative risks of developing breast cancer are:
Nonproliferative (no increase in risk): cyst, ductal ectasia, fibroadenoma, mastitis, fibrosis, squamous or apocrine metaplasia, mild hyperplasia
Benign histologies associated relative risks of developing breast cancer are:
Proliferative without atypia (RR 1.5-2.0): complex fibroadenoma, papilloma, sclerosing adenoma, moderate or severe hyperplasia
Proliferative with atypia (RR 4.0-5.0):
atypical lobular hyperplasia,
atypical ductal hyperplasia